The additional predictive ability comes from an increase in sensitivity when adding in NR2, so that by using the levels of GFAP and of NR2 RNMDA antibodies, at 12 hrs after onset, we can identify with a very good sensitivity and specificity (94% and 91%, respectively) the type of stroke. The gene discussed is GFAP; the disease is stroke disorder.